Cite Filings / MTRI / 0001062993-26-003132
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Mentari Therapeutics, Inc. · Filed 2026-06-10 · Acc 0001062993-26-003132

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , form8k.htm

Around this filing

  • 2026-07-10 8-K Material agreement · Regulation FD disclosure
  • 2026-06-10 SCHEDULE 13D Beneficial Ownership Report
  • 2026-06-10 4 10% owner bought 249,227 shares at an average $1.57 ($391,555)
  • 2026-06-10 3 Initial Statement of Ownership
  • 2026-06-10 8-K Other events
  • 2026-06-05 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-19 8-K Material agreement · Change in control · Executive or director change · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading form8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…